Evome Medical Technologies Inc.
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Evome Medical Technologies Inc. (EVMT) - Net Assets
Latest net assets as of August 2024: CA$-3.43 Million CAD
Based on the latest financial reports, Evome Medical Technologies Inc. (EVMT) has net assets worth CA$-3.43 Million CAD as of August 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$35.13 Million) and total liabilities (CA$38.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-3.43 Million |
| % of Total Assets | -9.76% |
| Annual Growth Rate | -19.42% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 71.54 |
Evome Medical Technologies Inc. - Net Assets Trend (2019–2023)
This chart illustrates how Evome Medical Technologies Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Evome Medical Technologies Inc. (2019–2023)
The table below shows the annual net assets of Evome Medical Technologies Inc. from 2019 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-11-30 | CA$4.00 Million | -69.56% |
| 2021-11-30 | CA$13.15 Million | +98.04% |
| 2020-11-30 | CA$6.64 Million | -30.06% |
| 2019-11-30 | CA$9.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Evome Medical Technologies Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3853876200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$68.87 Million | 1720.29% |
| Total Equity | CA$4.00 Million | 100.00% |
Evome Medical Technologies Inc. Competitors by Market Cap
The table below lists competitors of Evome Medical Technologies Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TAKEDA PHARMA (TKD.SG)
STU:TKD
|
$284.05K |
|
Siwani Makmur Tbk
JK:SIMA
|
$284.29K |
|
Utron Ltd
TA:UTRN
|
$284.45K |
|
Averbuch Formica Center Ltd
TA:AVER
|
$284.46K |
|
Albaraka Turk Katilim Bankasi AS
IS:ALBRK
|
$283.95K |
|
Capitan Investment Ltd
V:CAI
|
$283.50K |
|
Nate's Food Co
PINK:NHMD
|
$283.41K |
|
Neste Corp
STU:NEF
|
$283.30K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evome Medical Technologies Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2023, total equity changed from 13,153,163 to 4,003,258, a change of -9,149,905 (-69.6%).
- Net loss of 15,602,915 reduced equity.
- Other factors increased equity by 6,453,010.
Equity Change Factors (2021 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-15.60 Million | -389.76% |
| Other Changes | CA$6.45 Million | +161.19% |
| Total Change | CA$- | -69.56% |
Book Value vs Market Value Analysis
This analysis compares Evome Medical Technologies Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.10x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-11-30 | CA$0.28 | CA$0.01 | x |
| 2020-11-30 | CA$0.20 | CA$0.01 | x |
| 2021-11-30 | CA$0.24 | CA$0.01 | x |
| 2023-11-30 | CA$0.05 | CA$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evome Medical Technologies Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -389.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.91%
- • Asset Turnover: 1.30x
- • Equity Multiplier: 12.05x
- Recent ROE (-389.76%) is below the historical average (-127.27%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -20.26% | -546.43% | 0.04x | 1.02x | CA$-2.87 Million |
| 2020 | -65.83% | -23.87% | 1.39x | 1.98x | CA$-5.04 Million |
| 2021 | -33.24% | -23.87% | 0.43x | 3.24x | CA$-5.69 Million |
| 2023 | -389.76% | -24.91% | 1.30x | 12.05x | CA$-16.00 Million |
Industry Comparison
This section compares Evome Medical Technologies Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $-1,434,148
- Average return on equity (ROE) among peers: -363.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evome Medical Technologies Inc. (EVMT) | CA$-3.43 Million | -20.26% | N/A | $284.04K |
| Cheelcare Inc. (CHER) | $-1.89 Million | 0.00% | 0.00x | $11.70K |
| Frequency Exchange Corp. (FREQ) | $334.04K | -1454.44% | 3.18x | $6.07 Million |
| Imaging Dynamics Company Ltd (IDL) | $-644.55K | 0.00% | 0.00x | $288.10K |
| VVT Med Inc. (VVTM) | $-3.54 Million | 0.00% | 0.00x | $8.84 Million |